Product
Aviptadil
4 clinical trials
7 indications
Indication
COVID-19Indication
Coronavirus InfectionIndication
ARDSIndication
AviptadilIndication
COVID-19 with Respiratory FailureIndication
Acute Respiratory Distress SyndromeIndication
ALIClinical trial
Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS: A Randomized, Placebo Controlled, Multicenter TrialStatus: Terminated, Estimated PCD: 2023-06-14
Clinical trial
I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill PatientsStatus: Recruiting, Estimated PCD: 2028-07-31
Clinical trial
ZYESAMI (Aviptadil) for the Treatment of Critical COVID-19 With Respiratory FailureStatus: Completed, Estimated PCD: 2021-02-22
Clinical trial
A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients With Acute Respiratory Distress Syndrome Associated With COVID-19Status: Completed, Estimated PCD: 2022-08-22